The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6527775 7014375 F 2 6527775-X 20080504 20091218 20091231 EXP 8033874 UCB. INC. 80 F N 55 KG 20091230 CZECH REPUBLIC

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6527775 1012904014 PS CERTOLIZUMAB PEGOL (CDP870) 2 SUBCUTANEOUS (400 MG, ONCE MONTHLY SUBCUTANEOUS), (400 MG , DOSE FREQ. : ONCE MONTHLY SUBCUTANEOUS) Y

Indications of drugs used

Event ID DRUG SEQ INDI PT
6527775 1012904014 RHEUMATOID ARTHRITIS

Outcome of event

Event ID OUTC COD
6527775 HO

Reactions reported

Event ID PT
6527775 BLOOD CREATININE INCREASED
6527775 CALCULUS URETERIC
6527775 CULTURE URINE POSITIVE
6527775 ESCHERICHIA URINARY TRACT INFECTION
6527775 HYDRONEPHROSIS
6527775 PYELONEPHRITIS

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
6527775 FGN
6527775 HP
6527775 SDY

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6527775 1012904014 20040602 20080519
6527775 1012904014 20031016